AstraZeneca vaccine approval to give Canada ‘greater flexibility’ in distributing doses widely, says health official
Procurement Minister Anita Anand suggests the latest approval marks a vindication of the 'diversification' strategy the government settled on as it moved to negotiate deals with seven 'leading' vaccine manufacturers.
Dr. Supriya Sharma, chief medical adviser with Health Canada, pictured in December 2020, cautions against placing too much emphasis on the efficacy rate of the AstraZeneca vaccine. She says a key metric of a vaccine's benefits is whether it reduces or eliminates the likelihood of hospitalization and death due to the virus. The Hill Times photograph by Andrew Meade